Procurement Summary
Country : USA
Summary : Drug Development Course
Deadline : 08 Oct 2024
Other Information
Notice Type : Tender
TOT Ref.No.: 107784449
Document Ref. No. : 75A01RFI250001
Financier : Self Financed
Purchaser Ownership : Public
Tender Value : Refer Document
Purchaser's Detail
Name :Login to see tender_details
Address : Login to see tender_details
Email : Login to see tender_details
Login to see detailsTender Details
Description
Period of Performance 3 December 2024 to 4 December 2024Place of Performance Constitution Center, Washington, DCProduct Service Code (PSC) U099 - Education/TrainingNorth American Industry Classification System (NAICS) Code 611430 = Professional and Management Development Training (size standard $15 million)NOTE: All prospective contractors must be registered in the System for Award Management (SAM.gov) database to be awarded a contract.Request for Information: The Center for the Biomedical Advanced Research and Development Authority (BARDA) is seeking potential contractors that can provide an in person, instructor-led course focused on the regulatory, commercial, and scientific considerations required to bring a drug successfully to market, based on the below learning objectives. The Contractor will provide a qualified instructor for the course. The requested Period of Coverage is from 3 December 2024 to 4 December 2024.Scope: Contractor will perform in-person, instructor led training on the topic of Drug Development for Scientists. The course will be for up to 30 attendees in the Constitution Center Washington DC. Course materials (ex. PowerPoint Slides; workbooks) are the responsibility of the Contractor and must follow 508 compliance. (https://www.section508.gov/). Final Course materials should be submitted to the CO at least 2 business days prior course commencement. A copy of the Statement of Objectives (SOO) is attached to this RFI.Learning Objectives:• Discovery pathway for o Large and small molecules o Gene therapy o Vaccines• Drug target identification and validation• Discovery flow to identify drug candidate, lead candidate, and lead candidate optimization. o Preclinical development o Decision milestones and go/no go criteria. o Target product profile o Nonclinical studies o Toxicology, Pharmacokinetics/Pharmacodynamics o Phases of clinical trials; what data is generated and how does that inform subsequent trial design? o Drafting a drug la...
Active Contract Opportunity
Notice ID : 75A01RFI250001
Related Notice
Department/Ind. Agency : HEALTH AND HUMAN SERVICES, DEPARTMENT OF
Sub-tier : ADMINISTRATION FOR STRATEGIC PREPAREDNESS AND RESPONSE :
General Information
Contract Opportunity Type: Special Notice (Original)
Original Published Date: Sep 26, 2024 04:47 pm EDT
Original Response Date: Oct 08, 2024 02:00 pm EDT
Inactive Policy: 15 days after response date
Original Inactive Date: Oct 23, 2024
Initiative: None
Classification
Original Set Aside:
Product Service Code: U099 - EDUCATION/TRAINING- OTHER
NAICS Code: 611430 - Professional and Management Development Training
Place of Performance: Washington, DC 20024 USA
Documents
Tender Notice
RFI-Drug-Development-Course.pdf
SOO-Drug-Development-Course-RFI.pdf